Literature DB >> 28009409

A survey of management of congenital nasolacrimal duct obstruction by pediatric primary health care providers in Spain.

Alicia Galindo-Ferreiro1,2, Teresa Palencia-Ercilla3, Livia Mendoza Ferreira4, Alberto Galvez-Ruiz1, Denise C M Zornoff5, Rajiv Khandekar6, Silvana A Schellini4.   

Abstract

PURPOSE: To survey the management of congenital nasolacrimal duct obstruction (CNLDO) by pediatric primary health care providers in Spain.
METHODS: This was a descriptive study using a web-based questionnaire to evaluate the perceptions of the members of the Pediatric Primary Care Society in Castilla-León, Spain (APAPCYL), regarding management of CNLDO. The questionnaire contained 14 direct questions and was sent by e-mail to all the pediatricians. All the responses were analyzed by the frequency of occurrence and percentages.
RESULTS: Ninety physicians responded to the questionnaire. Massage 2 or 3 times a day was the initial treatment advised by 60.47% of pediatricians. Nearly half of the pediatricians recommended continuing massage until symptoms resolved. Fewer than 50% of children required referral to an ophthalmologist. Reasons for an ophthalmic consult included persistence of symptoms among 87.21% of pediatricians and parental/guardian request among 10.5% of pediatricians. According to 45.6% of pediatricians, their knowledge about CNLDO is limited, and 92.2% would like to receive further training on CNLDO.
CONCLUSIONS: Massage was the main initial treatment for managing CNLDO among pediatricians. The outcomes of this survey indicated that massage fails in fewer than 50% of patients and an ophthalmic referral is required for these cases.

Entities:  

Mesh:

Year:  2016        PMID: 28009409     DOI: 10.5301/ejo.5000915

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  1 in total

1.  Spontaneous resolution rates in congenital nasolacrimal duct obstruction managed with massage or topical antibiotics compared with observation alone.

Authors:  Brian G Mohney; Saraniya Sathiamoorthi; Ryan D Frank
Journal:  Br J Ophthalmol       Date:  2021-03-17       Impact factor: 5.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.